Tearsheet

Owens & Minor (OMI)

Market Price (11/6/2025): $3.29 | Market Cap: $254.3 Mil
Sector: Health Care | Industry: Health Care Distributors

Owens & Minor (OMI)

Market Price (11/6/2025): $3.29
Market Cap: $254.3 Mil
Sector: Health Care
Industry: Health Care Distributors

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0	Strong revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 92%	Weak multi-year price returns 2Y Excs Rtn is -137%, 3Y Excs Rtn is -156%	Debt is significant Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 836%
1	Valuation becoming less expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -47%		Not cash flow generative FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -2.8%
2			Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -522%

0	Strong revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 92%
1	Valuation becoming less expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -47%
2	Weak multi-year price returns 2Y Excs Rtn is -137%, 3Y Excs Rtn is -156%
3	Debt is significant Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 836%
4	Not cash flow generative FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -2.8%
5	Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -522%

Market Valuation & Key Metrics

	11/6/25	2024	2023	2022	2021
Share Price CYE	$3.29	$13.07	$19.27	$19.53	$43.50
Market Cap CYE ($ Mil)	254.3	1,006.3	1,465.8	1,461.9	3,176.8
Total Debt ($ Mil)	2,196.6	2,139.8	2,319.9	2,716.3	1,109.8
Total Cash ($ Mil)	32.8	49.4	243.0	69.5	55.7
Enterprise Value ($ Mil)	2,418.1	3,146.1	3,785.7	4,178.2	4,286.6
Valuation Ratios
P/S TTM	0.0	0.1	0.1	0.1	0.3
P/EBIT TTM	-0.8	-4.7	14.2	10.4	9.7
P/E TTM	-0.2	-2.8	-35.4	65.0	14.3
Sector Ratios
P/S TTM (Sector)	3.9	3.5	4.0	4.6	7.3
P/EBIT TTM (Sector)	-1.6	-1.3	-1.3	-1.3	-2.7
P/E TTM (Sector)	-1.8	-1.5	-1.5	-1.3	-2.8

	11/6/25	2024	2023
Share Price CYE	$3.29	$13.07	$19.27
Market Cap CYE ($ Mil)	254.3	1,006.3	1,465.8
Total Debt ($ Mil)	2,196.6	2,139.8	2,319.9
Total Cash ($ Mil)	32.8	49.4	243.0
Enterprise Value ($ Mil)	2,418.1	3,146.1	3,785.7
Valuation Ratios
P/S TTM	0.0	0.1	0.1
P/EBIT TTM	-0.8	-4.7	14.2
P/E TTM	-0.2	-2.8	-35.4
Sector Ratios
P/S TTM (Sector)	3.9	3.5	4.0
P/EBIT TTM (Sector)	-1.6	-1.3	-1.3
P/E TTM (Sector)	-1.8	-1.5	-1.5

null

AI Generated Analysis | Feedback

null

OMI Stock

Return (1M):

Factor Drivers of Stock Movement

The -47.9% change in OMI stock from 8/6/2025 to 11/5/2025 was primarily driven by a -48.0% change in the company's P/S Multiple.

	8062025	11052025	Change
Stock Price ($)	6.43	3.35	-47.90%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	12695.09	12727.02	0.25%
P/S Multiple	0.04	0.02	-48.02%
Shares Outstanding (Mil)	77.27	77.29	-0.02%
Cumulative Contribution			-47.90%

LTM = Last Twelve Months as of date shown

The -56.8% change in OMI stock from 5/7/2025 to 11/5/2025 was primarily driven by a -56.8% change in the company's P/S Multiple.

	5072025	11052025	Change
Stock Price ($)	7.76	3.35	-56.83%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	12675.72	12727.02	0.40%
P/S Multiple	0.05	0.02	-56.84%
Shares Outstanding (Mil)	76.99	77.29	-0.38%
Cumulative Contribution			-56.83%

LTM = Last Twelve Months as of date shown

The -71.6% change in OMI stock from 11/5/2024 to 11/5/2025 was primarily driven by a -85.2% change in the company's P/S Multiple.

	11052024	11052025	Change
Stock Price ($)	11.80	3.35	-71.61%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	6616.08	12727.02	92.37%
P/S Multiple	0.14	0.02	-85.20%
Shares Outstanding (Mil)	77.09	77.29	-0.26%
Cumulative Contribution			-71.61%

LTM = Last Twelve Months as of date shown

The -82.5% change in OMI stock from 11/6/2022 to 11/5/2025 was primarily driven by a -86.0% change in the company's P/S Multiple.

	11062022	11052025	Change
Stock Price ($)	19.14	3.35	-82.50%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	9871.51	12727.02	28.93%
P/S Multiple	0.15	0.02	-85.99%
Shares Outstanding (Mil)	74.91	77.29	-3.18%
Cumulative Contribution			-82.52%

LTM = Last Twelve Months as of date shown

Why The Stock Moved

AI Generated Analysis | Feedback

Here are the key points explaining the approximate -51.7% stock movement for Owens & Minor (OMI) from July 31, 2025, to November 6, 2025:

1. Q2 2025 Earnings Miss and Rotech Acquisition Termination Costs: Owens & Minor reported mixed second-quarter 2025 results on August 11, 2025, with adjusted earnings per share (EPS) of $0.26 missing analyst expectations and revenue significantly below estimates due to the classification of a segment as discontinued operations. A substantial $80 million transaction breakage fee related to the terminated Rotech acquisition also led to a GAAP loss of $1.09 per share, triggering an immediate negative market reaction.

2. Strategic Pivot and Underperformance of Core Business: While the company strategically pivoted to become a "pure-play Patient Direct business" by divesting its Products & Healthcare Services (PHS) segment, the remaining core Patient Direct business showed concerning deceleration in its Q3 2025 performance. It experienced a 16% drop in core Adjusted Operating Income and severe margin compression. The divestiture itself also introduced "stranded costs" and raised concerns about the company's reduced scope and business diversity.

3. Deteriorating Balance Sheet and Increased Leverage: By the third quarter of 2025, the strategic transition contributed to a negative GAAP equity deficit of $(430) million and a rise in total debt to $2.1 billion, compounded by a 553% spike in near-term debt obligations. Earlier in 2025, S&P Global Ratings had already revised its outlook for Owens & Minor to negative due to higher-than-expected leverage, anticipating it to exceed 5x in 2025.

4. Persistent Unprofitability and Negative Future Outlook: Owens & Minor remained unprofitable, with losses accelerating. Analysts noted expectations for a sharp decline in revenue, projected at 46.5% per year over the next three years, and profit margins continuing in negative territory without clear signs of improvement. This long-term negative outlook contributed to sustained investor apprehension.

5. Analyst Downgrade: On November 3, 2025, UBS downgraded Owens & Minor from a "Buy" to a "Neutral" rating and significantly cut its price target from $7 to $4. This downgrade by a major financial institution likely exacerbated negative market sentiment and put further downward pressure on the stock price.

Show less

Return vs. Risk

Price Returns Compared

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
OMI Return	424%	61%	-55%	-1%	-32%	-74%	-35%
Peers Return	11%	20%	27%	16%	9%	36%	189%
S&P 500 Return	16%	27%	-19%	24%	23%	16%	110%
Monthly Win Rates [3]
OMI Win Rate	83%	67%	25%	42%	50%	20%
Peers Win Rate	40%	45%	50%	50%	45%	54%
S&P 500 Win Rate	58%	75%	42%	67%	75%	70%
Max Drawdowns [4]
OMI Max Drawdown	-20%	-6%	-65%	-38%	-39%	-74%
Peers Max Drawdown	-17%	-5%	-4%	-11%	-4%	-2%
S&P 500 Max Drawdown	-31%	-1%	-25%	-1%	-2%	-15%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: MCK, CAH, HSIC, EMPG, COR. See OMI Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 11/5/2025 (YTD)

How Low Can It Go

Unique Key	Event	OMI	S&P 500
2022 Inflation Shock	2022 Inflation Shock
2022 Inflation Shock% Loss	% Loss	-75.1%	-25.4%
2022 Inflation Shock% Gain to Breakeven	% Gain to Breakeven	302.3%	34.1%
2022 Inflation ShockTime to Breakeven	Time to Breakeven	Not Fully Recovered days	464 days
2020 Covid Pandemic	2020 Covid Pandemic
2020 Covid Pandemic% Loss	% Loss	-42.7%	-33.9%
2020 Covid Pandemic% Gain to Breakeven	% Gain to Breakeven	74.5%	51.3%
2020 Covid PandemicTime to Breakeven	Time to Breakeven	18 days	148 days
2018 Correction	2018 Correction
2018 Correction% Loss	% Loss	-93.3%	-19.8%
2018 Correction% Gain to Breakeven	% Gain to Breakeven	1396.0%	24.7%
2018 CorrectionTime to Breakeven	Time to Breakeven	604 days	120 days
2008 Global Financial Crisis	2008 Global Financial Crisis
2008 Global Financial Crisis% Loss	% Loss	-37.8%	-56.8%
2008 Global Financial Crisis% Gain to Breakeven	% Gain to Breakeven	60.7%	131.3%
2008 Global Financial CrisisTime to Breakeven	Time to Breakeven	756 days	1480 days

Compare to MCK, CAH, HSIC, EMPG, COR

In The Past

Owens & Minor's stock fell -75.1% during the 2022 Inflation Shock from a high on 6/8/2021. A -75.1% loss requires a 302.3% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Owens & Minor (OMI)

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. It provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

null

Better Bets than Owens & Minor (OMI)

	OMI	Better Performance than OMI
Metric	Value	Industry (Health Care Distributors)
Rev Chg LTM	92.4%
Rev Chg 3Y Avg	20.2%	QIPT (24.7%)
Op Mgn LTM	2.6%	HSIC (5.9%), SNYR (17.7%)
CFO/Rev LTM	-0.8%	MCK (1.7%), COR (0.6%), CAH (1.1%), HSIC (4.1%), QIPT (15.9%)
FCF/Rev LTM	-2.8%	MCK (1.5%), COR (0.4%), CAH (0.8%), HSIC (2.8%), QIPT (10.0%)
Total Yield	-517.7%	MCK (3.3%), COR (3.4%), CAH (4.4%), HSIC (4.5%), QIPT (-9.9%)

	OMI	Better Performance than OMI
Metric	Value	Sector (Health Care)
Rev Chg LTM	92.4%	MDGL (864.2%), CYTK (2635.7%), KRYS (116.1%), PTCT (97.5%), ARWR (2816.2%)
Rev Chg 3Y Avg	20.2%	LLY (23.4%), ALNY (51.4%), INSM (22.8%), NTRA (39.7%), PODD (26.1%)
Op Mgn LTM	2.6%	LLY (43.0%), JNJ (26.2%), ABBV (24.1%), UNH (6.1%), ABT (17.6%)
CFO/Rev LTM	-0.8%	LLY (20.5%), JNJ (26.3%), ABBV (35.0%), UNH (4.8%), ABT (20.8%)
FCF/Rev LTM	-2.8%	LLY (-0.1%), JNJ (20.3%), ABBV (33.0%), UNH (4.0%), ABT (15.8%)
Total Yield	-517.7%	LLY (2.3%), JNJ (8.3%), ABBV (3.6%), UNH (8.6%), ABT (8.3%)

	OMI	Better Performance than OMI
Metric	Value	All Other Sectors
Rev Chg LTM	92.4%	ALAB (136.5%), CRDO (175.8%), STLA (156.0%), NBIS (542.6%), EXE (169.1%)
Rev Chg 3Y Avg	20.2%	NVDA (92.0%), AVGO (24.0%), PLTR (29.3%), MU (20.3%), SHOP (26.8%)
Op Mgn LTM	2.6%	NVDA (58.1%), AAPL (31.9%), MSFT (46.3%), GOOGL (32.2%), AMZN (11.4%)
CFO/Rev LTM	-0.8%	NVDA (46.6%), AAPL (26.6%), MSFT (50.0%), GOOGL (39.3%), AMZN (18.1%)
FCF/Rev LTM	-2.8%	NVDA (43.6%), AAPL (23.5%), MSFT (26.6%), GOOGL (19.1%), AMZN (2.0%)
Total Yield	-517.7%	NVDA (1.8%), AAPL (2.8%), MSFT (3.4%), GOOGL (3.9%), AMZN (2.7%)

		Best Bets In Health Care Sector
	OMI	RPRX	HALO	CPRX	BMY	LNTH	MEDP	PBH	MRK	NBIX	ISRG
What You Pay
P/E	-0.2	22.8	13.4	12.5	15.7	14.5	38.9	13.9	11.1	35.7	71.2
P/EBIT	-0.9	11.0	10.5	10.7	9.5	9.9	33.2	8.9	9.1	26.2	69.5
What You Get
Rev Chg Q	1.5%	7.9%	22.1%	19.4%	2.8%	-4.1%	23.7%	-6.6%	3.7%	27.8%	22.9%
Rev Chg LTM	92.4%	3.7%	31.2%	28.5%	1.3%	5.7%	13.9%	0.6%	1.7%	19.6%	22.2%
Rev Chg 3Y Avg	20.2%	1.5%	29.0%	49.9%	1.0%	34.3%	19.9%	0.8%	2.9%	24.6%	16.3%
FCF/Rev 3Y Avg	0.7%	115.2%	45.0%	38.9%	29.0%	26.1%	25.3%	21.6%	22.0%	21.1%	16.5%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 11%, alpha of 1.9%, and sharpe of 0.52

Latest Trefis Analyses

	Title	Topic	Date
0	DASHBOARDS
1	null
2	Day 5 of Loss Streak for Owens & Minor Stock with -11% Return (vs. -61% YTD) [8/22/2025]	Notification
3	Owens & Minor (OMI) Operating Cash Flow Comparison	Financials
4	Owens & Minor (OMI) Operating Income Comparison	Financials
5	Owens & Minor (OMI) Net Income Comparison	Financials
6	Owens & Minor (OMI) Debt Comparison	Financials
7	Owens & Minor (OMI) EBITDA Comparison	Financials
8	Owens & Minor (OMI) Tax Expense Comparison	Financials
9	Owens & Minor (OMI) Revenue Comparison	Financials
10	OMI Dip Buy Analysis
11	ARTICLES
12	OMI Stock Down -11% after 5-Day Loss Streak		August 22nd, 2025
13	Market Movers \| Winners: TLRY, TGNA, MLNK \| Losers: OMI, AI, MAX		August 12th, 2025
14	OMI Stock Up 29% after 6-Day Win Streak		July 2nd, 2025
15	Is There A Better Pick Over Owens & Minor Stock?		March 18th, 2022
16	Is A Fall Imminent In Owens & Minor Stock After A Large 38% Rise In A Month?		November 9th, 2021

	Title
0	DASHBOARDS
1	null
2	Day 5 of Loss Streak for Owens & Minor Stock with -11% Return (vs. -61% YTD) [8/22/2025]
3	Owens & Minor (OMI) Operating Cash Flow Comparison
4	Owens & Minor (OMI) Operating Income Comparison
5	Owens & Minor (OMI) Net Income Comparison
6	Owens & Minor (OMI) Debt Comparison
7	Owens & Minor (OMI) EBITDA Comparison
8	Owens & Minor (OMI) Tax Expense Comparison
9	Owens & Minor (OMI) Revenue Comparison
10	OMI Dip Buy Analysis
11	ARTICLES
12	OMI Stock Down -11% after 5-Day Loss Streak
13	Market Movers \| Winners: TLRY, TGNA, MLNK \| Losers: OMI, AI, MAX
14	OMI Stock Up 29% after 6-Day Win Streak
15	Is There A Better Pick Over Owens & Minor Stock?
16	Is A Fall Imminent In Owens & Minor Stock After A Large 38% Rise In A Month?

Trade Ideas

Select past ideas related to OMI. For more, see Trefis Trade Ideas.

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
GDRX_10312025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	10312025	GDRX	GoodRx	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	-1.2%	-1.2%	-3.3%
DXCM_10312025_Monopoly_xInd_xCD_Getting_Cheaper	10312025	DXCM	DexCom	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	1.8%	1.8%	0.0%
ACHC_10242025_Dip_Buyer_ValueBuy	10242025	ACHC	Acadia Healthcare	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	-11.6%	-11.6%	-11.7%
PBH_10102025_Dip_Buyer_ValueBuy	10102025	PBH	Prestige Consumer Healthcare	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	-1.9%	-1.9%	-1.9%
REGN_10032025_Dip_Buyer_ValueBuy	10032025	REGN	Regeneron Pharmaceuticals	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	7.4%	7.4%	-7.0%
OMI_6302024_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	06302024	OMI	Owens & Minor	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	-4.1%	-32.6%	-53.9%
OMI_3312023_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	03312023	OMI	Owens & Minor	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	11.1%	90.4%	-6.9%
OMI_9302022_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	09302022	OMI	Owens & Minor	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	-39.6%	-32.9%	-49.8%

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
GDRX_10312025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	10312025	GDRX	GoodRx	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	-1.2%	-1.2%	-3.3%
DXCM_10312025_Monopoly_xInd_xCD_Getting_Cheaper	10312025	DXCM	DexCom	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	1.8%	1.8%	0.0%
ACHC_10242025_Dip_Buyer_ValueBuy	10242025	ACHC	Acadia Healthcare	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	-11.6%	-11.6%	-11.7%
PBH_10102025_Dip_Buyer_ValueBuy	10102025	PBH	Prestige Consumer Healthcare	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	-1.9%	-1.9%	-1.9%
REGN_10032025_Dip_Buyer_ValueBuy	10032025	REGN	Regeneron Pharmaceuticals	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	7.4%	7.4%	-7.0%
OMI_6302024_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	06302024	OMI	Owens & Minor	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	-4.1%	-32.6%	-53.9%
OMI_3312023_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	03312023	OMI	Owens & Minor	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	11.1%	90.4%	-6.9%
OMI_9302022_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	09302022	OMI	Owens & Minor	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	-39.6%	-32.9%	-49.8%

Recent Active Movers

1 Day Top Gainers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
SLDP	Solid Power	1.5	51.6%	350.3%
LMND	Lemonade	5.8	34.2%	114.6%
RIGL	Rigel Pharmaceuticals	0.7	33.4%	125.0%
TDC	Teradata	2.6	32.6%	-11.8%
KW	Kennedy-Wilson	1.4	31.2%	2.7%
SEDG	SolarEdge Technologies	2.4	28.9%	201.6%
VCYT	Veracyte	3.6	27.5%	16.3%
AIP	Arteris	0.6	26.1%	52.4%
DAWN	Day One Biopharmaceuticals	0.9	25.2%	-27.9%
ALGT	Allegiant Travel	1.3	25.1%	-22.9%

1 Day Top Losers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
BHVN	Biohaven	0.9	-40.2%	-77.7%
TREX	Trex	3.5	-31.1%	-53.0%
SLNO	Soleno Therapeutics	2.4	-26.6%	4.3%
PRGO	Perrigo	2.1	-25.2%	-39.3%
WWW	Wolverine World Wide	1.4	-24.3%	-23.1%
PINS	Pinterest	17.4	-21.8%	-11.2%
ACMR	ACM Research	2.0	-19.9%	106.2%
RPD	Rapid7	0.9	-19.9%	-64.6%
INNV	InnovAge	0.5	-17.6%	1.5%
SUPN	Supernus Pharmaceuticals	2.6	-17.4%	30.3%

1 Week Top Gainers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
TERN	Terns Pharmaceuticals	1.7	126.8%	228.3%
SLDP	Solid Power	1.5	54.2%	350.3%
CSIQ	Canadian Solar	1.7	42.3%	124.8%
CSTL	Castle Biosciences	1.0	41.4%	26.0%
MTSR	Metsera	7.5	36.7%	71379900.0%
GH	Guardant Health	11.8	31.5%	211.1%
KW	Kennedy-Wilson	1.4	31.4%	2.7%
TDC	Teradata	2.6	30.5%	-11.8%
VCYT	Veracyte	3.6	30.0%	16.3%
DAWN	Day One Biopharmaceuticals	0.9	29.8%	-27.9%

1 Week Top Losers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
QURE	uniQure	1.4	-63.1%	47.6%
SOC	Sable Offshore	0.5	-57.2%	-75.2%
FMC	FMC	1.7	-54.0%	-71.3%
BHVN	Biohaven	0.9	-53.9%	-77.7%
DD	DuPont de Nemours	16.6	-51.8%	-47.2%
ALVO	Alvotech	1.4	-38.2%	-63.1%
WOLF	Wolfspeed	3.2	-36.7%
SVV	Savers Value Village	1.3	-35.2%	-16.1%
NWL	Newell Brands	1.3	-34.7%	-66.5%
APLS	Apellis Pharmaceuticals	2.5	-33.6%	-37.5%

1 Month Top Gainers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
PRAX	Praxis Precision Medicines	3.5	216.4%	113.9%
INBX	Inhibrx Biosciences	1.3	145.6%	434.2%
TERN	Terns Pharmaceuticals	1.7	127.7%	228.3%
VTYX	Ventyx Biosciences	0.6	126.1%	311.0%
PUMP	ProPetro	1.1	99.3%	16.2%
VICR	Vicor	4.3	95.1%	96.4%
REPL	Replimune	0.8	84.5%	-29.1%
SNDK	SanDisk	31.4	79.0%
CSIQ	Canadian Solar	1.7	73.3%	124.8%
ATXS	Astria Therapeutics	0.7	68.9%	41.2%

1 Month Top Losers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
SOC	Sable Offshore	0.5	-70.6%	-75.2%
FMC	FMC	1.7	-57.1%	-71.3%
QURE	uniQure	1.4	-55.0%	47.6%
DD	DuPont de Nemours	16.6	-49.8%	-47.2%
FI	Fiserv	35.3	-49.5%	-68.8%
LRN	Stride	3.1	-48.6%	-30.8%
ONDS	Ondas	0.9	-45.9%	134.4%
BHVN	Biohaven	0.9	-44.5%	-77.7%
LAC	Lithium Americas	1.0	-44.3%	55.2%
ALVO	Alvotech	1.4	-43.5%	-63.1%

Recent Active Movers

1 Day Top Gainers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
SLDP	Solid Power	1.5	51.6%	350.3%
LMND	Lemonade	5.8	34.2%	114.6%
RIGL	Rigel Pharmaceuticals	0.7	33.4%	125.0%
TDC	Teradata	2.6	32.6%	-11.8%
KW	Kennedy-Wilson	1.4	31.2%	2.7%
SEDG	SolarEdge Technologies	2.4	28.9%	201.6%
VCYT	Veracyte	3.6	27.5%	16.3%
AIP	Arteris	0.6	26.1%	52.4%
DAWN	Day One Biopharmaceuticals	0.9	25.2%	-27.9%
ALGT	Allegiant Travel	1.3	25.1%	-22.9%

1 Day Top Losers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
BHVN	Biohaven	0.9	-40.2%	-77.7%
TREX	Trex	3.5	-31.1%	-53.0%
SLNO	Soleno Therapeutics	2.4	-26.6%	4.3%
PRGO	Perrigo	2.1	-25.2%	-39.3%
WWW	Wolverine World Wide	1.4	-24.3%	-23.1%
PINS	Pinterest	17.4	-21.8%	-11.2%
ACMR	ACM Research	2.0	-19.9%	106.2%
RPD	Rapid7	0.9	-19.9%	-64.6%
INNV	InnovAge	0.5	-17.6%	1.5%
SUPN	Supernus Pharmaceuticals	2.6	-17.4%	30.3%

1 Week Top Gainers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
TERN	Terns Pharmaceuticals	1.7	126.8%	228.3%
SLDP	Solid Power	1.5	54.2%	350.3%
CSIQ	Canadian Solar	1.7	42.3%	124.8%
CSTL	Castle Biosciences	1.0	41.4%	26.0%
MTSR	Metsera	7.5	36.7%	71379900.0%
GH	Guardant Health	11.8	31.5%	211.1%
KW	Kennedy-Wilson	1.4	31.4%	2.7%
TDC	Teradata	2.6	30.5%	-11.8%
VCYT	Veracyte	3.6	30.0%	16.3%
DAWN	Day One Biopharmaceuticals	0.9	29.8%	-27.9%

1 Week Top Losers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
QURE	uniQure	1.4	-63.1%	47.6%
SOC	Sable Offshore	0.5	-57.2%	-75.2%
FMC	FMC	1.7	-54.0%	-71.3%
BHVN	Biohaven	0.9	-53.9%	-77.7%
DD	DuPont de Nemours	16.6	-51.8%	-47.2%
ALVO	Alvotech	1.4	-38.2%	-63.1%
WOLF	Wolfspeed	3.2	-36.7%
SVV	Savers Value Village	1.3	-35.2%	-16.1%
NWL	Newell Brands	1.3	-34.7%	-66.5%
APLS	Apellis Pharmaceuticals	2.5	-33.6%	-37.5%

Peer Comparisons for Owens & Minor

Financials

	OMI	MCK	CAH	HSIC	EMPG	COR	Median
Name	Owens & .	McKesson	Cardinal.	Henry Sc.	Empro	Cencora
Mkt Price	3.35	844.26	196.79	72.01	-	354.00	196.79
Mkt Cap	0.3	105.4	46.8	8.7	-	68.6	46.8
Rev LTM	12,727	377,595	222,578	12,938	-	316,654	222,578
Op Inc LTM	335	4,748	2,322	764	-	3,713	2,322
FCF LTM	-362	5,666	1,850	356	-	1,142	1,142
FCF 3Y Avg	47	4,463	2,488	455	-	2,588	2,488
CFO LTM	-99	6,547	2,397	535	-	1,742	1,742
CFO 3Y Avg	273	5,194	3,001	644	-	3,101	3,001

Growth & Margins

	OMI	MCK	CAH	HSIC	EMPG	COR	Median
Name	Owens & .	McKesson	Cardinal.	Henry Sc.	Empro	Cencora
Rev Chg LTM	92.4%	20.3%	-1.9%	3.5%	-	11.6%	11.6%
Rev Chg 3Y Avg	20.2%	12.2%	7.3%	0.9%	-	10.3%	10.3%
Rev Chg Q	1.5%	23.4%	0.5%	5.2%	-	8.7%	5.2%
QoQ Delta Rev Chg LTM	0.1%	5.2%	0.1%	1.3%	-	2.1%	1.3%
Op Mgn LTM	2.6%	1.3%	1.0%	5.9%	-	1.2%	1.3%
Op Mgn 3Y Avg	2.8%	1.4%	1.0%	5.7%	-	1.1%	1.4%
QoQ Delta Op Mgn LTM	-0.0%	-0.1%	0.0%	-0.1%	-	0.0%	-0.0%
CFO/Rev LTM	-0.8%	1.7%	1.1%	4.1%	-	0.6%	1.1%
CFO/Rev 3Y Avg	3.1%	1.6%	1.4%	5.1%	-	1.1%	1.6%
FCF/Rev LTM	-2.8%	1.5%	0.8%	2.8%	-	0.4%	0.8%
FCF/Rev 3Y Avg	0.7%	1.4%	1.1%	3.6%	-	0.9%	1.1%

Valuation

	OMI	MCK	CAH	HSIC	EMPG	COR	Median
Name	Owens & .	McKesson	Cardinal.	Henry Sc.	Empro	Cencora
Mkt Cap	0.3	105.4	46.8	8.7	-	68.6	46.8
P/S	0.0	0.3	0.2	0.7	-	0.2	0.2
P/EBIT	-0.9	23.1	20.2	12.9	-	23.4	20.2
P/E	-0.2	33.3	30.0	22.1	-	36.2	30.0
P/CFO	-2.6	16.1	19.5	16.2	-	39.4	16.2
Total Yield	-517.7%	3.3%	4.4%	4.5%	-	3.4%	3.4%
Dividend Yield	0.0%	0.3%	1.1%	0.0%	-	0.6%	0.3%
FCF Yield 3Y Avg	-19.0%	6.1%	9.2%	5.0%	-	5.9%	5.9%
D/E	8.5	0.1	0.2	0.4	-	0.1	0.2
Net D/E	8.4	0.1	0.1	0.4	-	0.1	0.1

Returns

	OMI	MCK	CAH	HSIC	EMPG	COR	Median
Name	Owens & .	McKesson	Cardinal.	Henry Sc.	Empro	Cencora
1M Rtn	-27.8%	13.9%	26.8%	9.0%	-	16.0%	13.9%
3M Rtn	-47.9%	20.1%	26.1%	8.6%	-	25.0%	20.1%
6M Rtn	-56.8%	17.1%	29.0%	8.2%	-	16.7%	16.7%
12M Rtn	-71.6%	61.4%	76.4%	4.4%	-	52.6%	52.6%
3Y Rtn	-82.5%	115.8%	162.1%	-0.9%	-	126.2%	115.8%
1M Excs Rtn	-30.8%	11.3%	24.4%	9.8%	-	13.5%	11.3%
3M Excs Rtn	-54.1%	20.2%	21.5%	2.1%	-	20.2%	20.2%
6M Excs Rtn	-77.5%	-3.6%	8.3%	-12.5%	-	-4.0%	-4.0%
12M Excs Rtn	-93.6%	42.5%	53.3%	-16.3%	-	33.7%	33.7%
3Y Excs Rtn	-155.8%	44.3%	99.1%	-70.3%	-	57.0%	44.3%

Financials

Annual
Quarterly

$ Mil \| FY: 12/31	LTM	2024	2023	2022	2021	2020	2019
Period End	9/30/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Filing Date	10/31/2025	2/28/2025	2/20/2024	2/28/2023	2/23/2022	2/24/2021	3/4/2020
Key Financials
Total Revenue	12,727	10,701	10,334	9,955	9,785	8,480	9,211
EBITDA	-50	51	391	368	415	287	186
Operating Income	335	296	305	277	442	242	103
Net Income	-1,340	-363	-41	22	222	30	-62
EPS	-17.40	-4.73	-0.54	0.30	3.05	0.47	-1.03
Growth Rates
Total Revenue Growth	92.4%	3.6%	3.8%	1.7%	15.4%	-7.9%	-2.2%
EBITDA Growth	-113.2%	-86.9%	6.0%	-11.3%	44.9%	54.0%	173.2%
Operating Income Growth	22.5%	-2.8%	10.1%	-37.4%	82.9%	134.4%	-14.5%
Net Income Growth	-2647.6%	-778.2%	-284.5%	-89.9%	641.8%	147.9%	85.7%
Margins
EBITDA Margin	-0.4%	0.5%	3.8%	3.7%	4.2%	3.4%	2.0%
Operating Income Margin	2.6%	2.8%	2.9%	2.8%	4.5%	2.9%	1.1%
Net Income Margin	-10.5%	-3.4%	-0.4%	0.2%	2.3%	0.4%	-0.7%
Cash & Debt
Total Cash	33	49	243	69	56	83	67
Total Debt	2,197	2,140	2,320	2,716	1,110	1,106	1,625
Net Debt / (Cash)	2,164	2,090	2,077	2,647	1,054	1,023	1,558
Cash Flows
Net Cash from Operations	-99	161	741	325	124	339	166
Free Cash from Operations	-362	-67	533	158	74	280	114
Returns to Shareholders
Dividends	0	-0	-0	-0	1	1	5
Share Repurchases	7	-0	-0	-0	-0	-0	-0

$ Mil \| FY: 12/31	2025Q3	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4
Period End	9/30/2025	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022
Filing Date	10/31/2025	8/11/2025	5/8/2025	2/28/2025	11/4/2024	8/2/2024	5/3/2024	2/20/2024	11/3/2023	8/4/2023	5/5/2023	2/28/2023
Key Financials Quarterly
Total Revenue	697	682	2,632	8,716	687	660	2,613	2,656	2,592	2,563	2,523	2,551
Ebitda	89	0	60	-200	92	80	83	129	101	82	79	19
Operating Income	56	57	61	161	59	46	57	111	84	62	48	-25
Net Income	-150	-869	-25	-296	-13	-32	-22	18	-6	-28	-24	-58
EPS	-1.94	-11.30	-0.32	-3.84	-0.17	-0.42	-0.29	0.23	-0.08	-0.37	-0.32	-0.77
Key Financials TTM
Total Revenue TTM	12,727	12,717	12,695	12,676	6,616	8,521	10,424	10,334	10,229	10,135	10,071	9,955
Ebitda TTM	-50	-48	31	54	383	392	394	391	281	298	363	368
Operating Income TTM	335	338	328	324	274	298	314	305	169	168	220	277
Net Income TTM	-1,340	-1,203	-366	-363	-49	-42	-39	-41	-117	-98	-41	22
Growth Rates Quarterly
Total Revenue Growth	1.5%	3.3%	0.7%	228.1%	-73.5%	-74.2%	3.6%	4.1%	3.8%	2.5%	4.8%	3.4%
EBITDA Growth	-2.2%	-99.4%	-27.3%	-255.9%	-9.2%	-2.3%	4.1%	578.0%	-14.3%	-44.5%	-6.0%	-77.3%
Operating Income Growth	-5.2%	23.1%	6.4%	45.5%	-29.4%	-25.6%	20.3%	541.0%	0.9%	-45.4%	-54.5%	-121.9%
Net Income Growth	-1076.8%	-2623.2%	-14.1%	-1765.1%	-98.7%	-13.0%	10.4%	130.7%	-151.4%	-198.7%	-162.2%	-238.2%
Margins Quarterly
EBITDA Margin	12.8%	0.1%	2.3%	-2.3%	13.3%	12.1%	3.2%	4.8%	3.9%	3.2%	3.1%	0.7%
Operating Income Margin	8.1%	8.3%	2.3%	1.8%	8.7%	7.0%	2.2%	4.2%	3.3%	2.4%	1.9%	-1.0%
Net Income Margin	-21.6%	-127.4%	-0.9%	-3.4%	-1.9%	-4.8%	-0.8%	0.7%	-0.2%	-1.1%	-1.0%	-2.3%
Cash & Debt
Total Cash	33	38	59	49	45	244	245	243	215	286	67	69
Total Debt	2,197	2,059	2,271	2,140	2,173	2,380	2,430	2,320	2,339	2,525	2,571	2,716
Net Debt / (Cash)	2,164	2,020	2,212	2,090	2,128	2,137	2,185	2,077	2,124	2,238	2,504	2,647
Cash Flows Quarterly
FCF from Operations	-173	38	-35	71	27	116	-53	112	157	313	158	87
Cash Flows TTM
FCF from Operations TTM	-99	101	179	161	202	332	529	741	716	627	404	325
Returns to Shareholders Quarterly
Dividends	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-0	5	2	-0	-0	-0	-0	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	8.2%	8.6%	6.2%	24.3%	8.8%	4.9%	6.8%	14.3%	7.4%	8.1%	4.5%	-1.9%
Return on Invested Capital (ROIC) TTM
ROIC TTM	12.2%	13.0%	11.8%	12.2%	6.6%	7.2%	9.3%	8.7%	4.3%	4.2%	4.2%	8.7%

Segment Financials

Assets by Segment

$ Mil	2024	2023	2022	2021	2020
Patient Direct	2,490	2,507	469
Products & Healthcare Services	2,360	2,810	3,012
Cash and cash equivalents	243	69	56	83	67
Global Products				1,135	931
Global Solutions				2,117	2,205
Discontinued operations					440
Total	5,093	5,386	3,537	3,336	3,643

Price Behavior

Price Behavior

Market Price	$3.35
Market Cap ($ Bil)	0.3
First Trading Date	12/16/1988
Distance from 52W High	-77.8%
	50 Days	200 Days
DMA Price	$4.94	$7.28
DMA Trend	down	down
Distance from DMA	-32.3%	-54.0%
	3M	1YR
Volatility	108.3%	92.2%
Downside Capture	350.65	220.79
Upside Capture	-109.16	59.23
Correlation (SPY)	12.4%	20.2%

OMI Betas & Captures as of 10/31/2025

	1M	2M	3M	6M	1Y	3Y
Beta	0.44	0.19	1.88	1.86	0.99	1.36
Up Beta	5.31	4.25	5.21	2.58	0.57	1.30
Down Beta	1.03	0.68	-0.07	1.12	0.68	1.00
Up Capture	-226%	-152%	3%	56%	79%	139%
Bmk +ve Days	14	27	37	74	145	425
Stock +ve Days	9	17	24	53	108	361
Down Capture	-44%	-64%	342%	266%	153%	110%
Bmk -ve Days	9	17	28	53	106	327
Stock -ve Days	14	26	40	72	139	383

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

1Y 5Y 10Y

Based On 1-Year Data

		Comparison of OMI With Other Asset Classes (Last 1Y)
	OMI	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	-73.6%	0.5%	20.3%	44.6%	1.0%	-2.3%	44.1%
Annualized Volatility	92.4%	17.0%	19.5%	19.9%	16.3%	18.0%	37.0%
Sharpe Ratio	-1.00	-0.14	0.82	1.74	-0.12	-0.28	0.78
Correlation With Other Assets		25.3%	20.4%	-8.9%	-9.0%	14.2%	2.0%

ETFs used for asset classes: Sector ETF = XLV, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How

Based On 5-Year Data

		Comparison of OMI With Other Asset Classes (Last 5Y)
	OMI	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	-33.0%	8.9%	17.3%	15.8%	13.5%	7.1%	50.1%
Annualized Volatility	70.3%	14.5%	17.1%	15.6%	18.9%	19.1%	49.2%
Sharpe Ratio	-0.26	0.44	0.83	0.81	0.59	0.28	0.77
Correlation With Other Assets		27.2%	28.4%	0.6%	2.6%	27.6%	10.8%

Based On 10-Year Data

		Comparison of OMI With Other Asset Classes (Last 10Y)
	OMI	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	-20.0%	9.2%	14.4%	12.7%	5.1%	5.1%	78.7%
Annualized Volatility	74.1%	16.7%	18.0%	14.7%	17.7%	20.9%	56.2%
Sharpe Ratio	0.02	0.45	0.69	0.71	0.22	0.21	0.96
Correlation With Other Assets		22.7%	22.7%	-0.7%	5.4%	19.8%	9.2%

Short Interest

Short Interest: As Of Date	10152025
Short Interest: Shares Quantity	8,415,055
Short Interest: % Change Since 9302025	7.9%
Average Daily Volume	1,889,962
Days-to-Cover Short Interest	4.45
Basic Shares Quantity	77,288,000
Short % of Basic Shares	10.9%

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
10/30/2025	-20.0%
8/11/2025	-34.7%	-19.9%	-22.0%
5/8/2025	-9.9%	-9.8%	3.2%
2/3/2025	-35.2%	-39.3%	-31.8%
11/4/2024	-10.2%	-3.4%	7.3%
7/23/2024	7.6%	0.8%	2.1%
5/3/2024	-25.7%	-25.0%	-28.5%
2/20/2024	1.6%	11.6%	19.1%
...
SUMMARY STATS
# Positive	8	8	12
# Negative	14	14	10
Median Positive	7.2%	12.7%	13.7%
Median Negative	-12.9%	-17.4%	-20.5%
Max Positive	29.2%	29.8%	46.3%
Max Negative	-35.2%	-39.3%	-33.7%

	Forward Returns
10/30/2025	-20.0%
8/11/2025	-34.7%	-19.9%	-22.0%
5/8/2025	-9.9%	-9.8%	3.2%
2/3/2025	-35.2%	-39.3%	-31.8%
11/4/2024	-10.2%	-3.4%	7.3%
7/23/2024	7.6%	0.8%	2.1%
5/3/2024	-25.7%	-25.0%	-28.5%
2/20/2024	1.6%	11.6%	19.1%
11/3/2023	27.1%	13.7%	46.3%
8/4/2023	1.3%	7.6%	-6.8%
2/28/2023	-21.8%	-20.9%	-33.7%
10/12/2022	-35.0%	-28.2%	-20.3%
8/3/2022	-11.5%	-9.2%	-19.5%
2/23/2022	6.7%	18.4%	17.8%
11/3/2021	22.3%	15.9%	8.9%
8/3/2021	-8.8%	-17.4%	-20.5%
5/5/2021	-8.0%	-3.9%	21.4%
2/24/2021	29.2%	29.8%	36.0%
11/2/2020	-2.3%	-13.7%	-3.5%
8/4/2020	-14.3%	-10.8%	4.2%
3/4/2020	-10.5%	-27.6%	19.2%
11/6/2019	1.6%	4.0%	9.6%
SUMMARY STATS
# Positive	8	8	12
# Negative	14	14	10
Median Positive	7.2%	12.7%	13.7%
Median Negative	-12.9%	-17.4%	-20.5%
Max Positive	29.2%	29.8%	46.3%
Max Negative	-35.2%	-39.3%	-33.7%

SEC Filings

Expand for More

Report Date	Filing Date	Filing
9302025	10312025	10-Q 9/30/2025
6302025	8112025	10-Q 6/30/2025
3312025	5082025	10-Q 3/31/2025
12312024	2282025	10-K 12/31/2024
9302024	11042024	10-Q 9/30/2024
6302024	8022024	10-Q 6/30/2024
3312024	5032024	10-Q 3/31/2024
12312023	2202024	10-K 12/31/2023
9302023	11032023	10-Q 9/30/2023
6302023	8042023	10-Q 6/30/2023
3312023	5052023	10-Q 3/31/2023
12312022	2282023	10-K 12/31/2022
9302022	11022022	10-Q 9/30/2022
6302022	8032022	10-Q 6/30/2022
3312022	5042022	10-Q 3/31/2022
12312021	2232022	10-K 12/31/2021

Insider Activity

Expand for More

Industry Resources

Health Care Resources

U.S. National Library of Medicine

Health Data Management

FDA Tracker

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Owens & Minor (OMI)

Market Price (11/6/2025): $3.29 | Market Cap: $254.3 MilSector: Health Care | Industry: Health Care Distributors

Owens & Minor (OMI)

Market Price (11/6/2025): $3.29Market Cap: $254.3 MilSector: Health CareIndustry: Health Care Distributors

Market Valuation & Key Metrics

OMI Stock

Return vs. Risk

Price Returns Compared

How Low Can It Go

In The Past

Preserve Wealth

Asset Allocation

About Owens & Minor (OMI)

Interactive Breakdown

Better Bets than Owens & Minor (OMI)

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Owens & Minor

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Based On 1-Year Data

Based On 5-Year Data

Based On 10-Year Data

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (11/6/2025): $3.29 | Market Cap: $254.3 Mil
Sector: Health Care | Industry: Health Care Distributors

Market Price (11/6/2025): $3.29
Market Cap: $254.3 Mil
Sector: Health Care
Industry: Health Care Distributors